Johnson & Johnson will buy Intra-Cellular Therapies for 14.31 billion euros
The multinational Johnson & Johnson will acquire Intra-Cellular Therapies, manufacturer of neurological drugs, for 14.31 billion euros ($14.6 billion). It ...
The multinational Johnson & Johnson will acquire Intra-Cellular Therapies, manufacturer of neurological drugs, for 14.31 billion euros ($14.6 billion). It ...